BioMarin Pharmaceuticals
BMRN
BMRN
533 hedge funds and large institutions have $11.1B invested in BioMarin Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 167 increasing their positions, 210 reducing their positions, and 127 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
7% less funds holding
Funds holding: 574 → 533 (-41)
20% less repeat investments, than reductions
Existing positions increased: 167 | Existing positions reduced: 210
22% less first-time investments, than exits
New positions opened: 99 | Existing positions closed: 127
Holders
533
Holding in Top 10
8
Calls
$120M
Puts
$70.8M
Top Buyers
| 1 | +$124M | |
| 2 | +$118M | |
| 3 | +$78.6M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$64M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$58.6M |
Top Sellers
| 1 | -$158M | |
| 2 | -$124M | |
| 3 | -$100M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$67.6M |
| 5 |
Man Group
London,
United Kingdom
|
-$61.6M |